Plausible State-Specific Plans and Recommendations to Avert COVID-19 Community Transmission
DOI:
https://doi.org/10.48165/Keywords:
Test Positivity Rate (TPR), Cumulative Test Positivity Rate (CTPR), Case Growth Rate / rate of growth of cases (CGR), Test Growth Rate / rate of growth of tests (TGR), Testing, COVID-19, State specific plan, Community transmissionAbstract
Current article emphasizes upon the strategy to increase the number of tests at the state-level so that majority of the suspected cases could be traced out, isolated and quarantined in order to contain them from becoming a source of infection and coronavirus disease-2019 (COVID-19) dissemination. The objective of the recommended testing is to contain the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Lessons learnt so far points to the fact that earlier the identification and isolation of infected person, lesser are the chances that it would spread. Considering an example of Maharashtra which has reported cases above 20,000 in the last 7 days with 90,000 tests carried out each day with a test positive report (TPR) of 22%-25%. So, assuming that even if 20% of a particular locality in Maharashtra is infected, then at this rate, we shall be able to isolate only 20,000 each day, while rest of the untraced cases already existing in the locality would pass it on to other people, before being isolated. The only solution to stop this cycle is to outnumber the rate of growth of new cases by increasing the number of tests at a very fast pace. In order to contain the infection, our testing rate has to be much higher than the case growth rate.
Downloads
References
Chakrabarti SS, Kaur U, Singh A, Chakrabarti S, Agrawal B, Mittal A, Singh A, Khanna R, Gambhir I, Jin K and Chakrabarti S (2020a). Of cross-immunity, herd immunity and country-
specific plans: Experiences from COVID-19 in India. Available at, https://dx.doi.org/10.2139/ssrn.3687256.
Chakrabarti SS, Kaur U, Banerjee A, Ganguly U, Banerjee T, Saha S, Parashar G, Prasad S, Chakrabarti S, Mittal A, Agrawal BK, Rawal RK, Zhao RC, Gambhir I, Khanna R, Shetty AK, Jin K and Chakrabarti S (2020b). COVID-19 in India: Are biological and environmental factors helping to stem the incidence and severity? Aging and Disease, 11(2): 480-488.
Dan S, Pant M and Upadhyay SK (2020). The case fatality rate (CFR) in SARS-COV-2 patients with cardiovascular disease (CVD): A global health risk paradigm in COVID-19 pandemic. Current Pharmacology Reports, https://doi.org/10.1007/s40495-020-00239-0.
DWB (2020). Data of World Bank. https://data.worldbank.org/indicator/ SH.MED.PHYS.ZS? World Bank Open Data. [Cited 2020 Aug 17].
Gupta R and Pal SK (2020). Trend analysis and forecasting of COVID-19 outbreak in India. MedRxiv, https://doi.org/10.1101/2020.03.26.20044511.
Jha D, Sharma V, Choudhary R, Sharma JK and Sharma AK (2020). Upsurge in Covid-19 testing versus latest trends of active patients in Indian scenario: Emerging trends and future predictions. Biochemical and Cellular Archives, 20(2sp): 3215-3221.
Keeling MJ, Hollingsworth TD and Read JM (2020). The efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19). MedRxiv, https://doi.org/10.1101/2020.02.14.20023036
Kumar G, Singh G, Bhatnagar V, Gupta R and Upadhyay SK (2020). Outcome of online teaching-learning over traditional education during covid-19 pandemic. International Journal of Advanced Trends in Computer Science and Engineering, 9(5): 7704–7711. https://doi.org/10.30534/ijatcse/2020/113952020.
Mbunge E (2020). Integrating emerging technologies into COVID-19 contact tracing: Opportunities, challenges and pitfalls. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 14(6): 1631-1636.
MoHaFWUoC-IcAA (2020). Ministry of health and family welfare. https://ssrn.com/abstract=3687256; https://pib.gov.in/PressReleasePage.aspx? PRID=1628696.
Ornell F, Schuch JB, Sordi AO and Kessler FHP (2020). Pandemic fear and COVID-19: Mental health burden and strategies. Brazilian Journal of Psychiatry, 42(3): 232-235.
Rocklöv J and Sjödin H (2020). High population densities catalyse the spread of COVID-19. Journal of Travel Medicine. 27(3): taaa038.
Sharma AK, Sharma V, Sharma A and Pallikkuth S (2020). Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions. Current Medicinal Chemistry, https://doi.org/10.2174/0929867327666200711153829.
Singh A, Gupte SS. Covid-19 Pandemic-Pits and falls of major states of India. medRxiv. 2020. 15. Sood S, Aggarwal V, Aggarwal D, Upadhyay SK, Sak K, Tuli HS, Kumar M, Kumar J and Talwar S (2020). Covid-19 pandemic: From molecular biology, pathogenesis, detection and treatment to global societal impact. Current Pharmacology Reports 6(5): 212–227, http://doi.org/10.1007/s40495-020-00229-2.
Trivedi M, Shingada A, Shah M, Khanna U, Karnik ND and Ramachandran R (2020). Impact of COVID‐19 on maintenance haemodialysis patients: The Indian scenario. Nephrology, e13760.
Upadhyay SK, Singh R, Babita, Kumar G and Singh G (2020a). The outbreak and challenges of novel coronavirus (COVID-19): The global pandemic emergency of early 2K20 and Indian scenario. International Journal of Biology Pharmacy and Allied Sciences, 9: 1173–1199. http://doi.org/10.31032/IJBPAS/2020/9.5.5126.
Upadhyay SK, Singh R, Singh M, Kumar V, Yadav M, Aggarwal D and Sehrawat N (2020b). COVID-19 in republic of India: A report on situation and precautionary strategies to global pandemic. Bulletin of Environment Pharmacology and Life Sciences, 9: 39–48.
Yadav R, Parihar RD, Dhiman U, Dhamija P, Upadhyay SK, Imran M, Behera SK and Prasad TSK (2020). Docking of FDA approved drugs targeting NSP-16, N-protein and main protease of SARS-CoV-2 as dual inhibitors. Biointerface Research in Applied Chemistry https://doi.org/10.33263/BRIAC113.98489861.
